Antitumor activity mediated by CpG: the route of administration is critical.

Lou Y, Liu C, Lizée G, Peng W, Xu C, Ye Y, Rabinovich BA, Hailemichael Y, Gelbard A, Zhou D, Overwijk WW, Hwu P
J Immunother. 2011 34 (3): 279-88

PMID: 21389870 · PMCID: PMC6119202 · DOI:10.1097/CJI.0b013e31820d2a05

MeSH Terms (20)

Animals Antigens, Neoplasm Antineoplastic Agents CD8-Positive T-Lymphocytes Chemokine CCL5 Chemokine CXCL10 Dendritic Cells Drug Administration Routes Female Humans Lymphocyte Activation Macrophage Inflammatory Proteins Mice Mice, Inbred Strains Monocyte Chemoattractant Proteins Neoplasms, Experimental Oligodeoxyribonucleotides Toll-Like Receptor 9 Tumor Burden Tumor Microenvironment

Connections (1)

This publication is referenced by other Labnodes entities: